Oppose proposals to require beneficiary coinsurance for Medicare clinical laboratory testing.     Medicare Part B reimbursement policies relating to clinical diagnostic testing; Congressional initiatives to implement the Budget Control Act of 2011 as related to Medicare reimbursement for clinical laboratory testing.      Oppose reduction to Medicare Clinical Laboratory Fee Schedule in the Middel Class Tax Relief and Job Creation Act of 2012 (H.R. 3630). Healthcare Reform Legislation and its impact on clinical laboratories and laboratory personnel; FDA initiatives to regulate laboratory-developed diagnostic tests; legislation concerning regulation of laboratory-developed diagnostic tests (including H.R. 3207).
MMM - Medicare/Medicaid MED - Medical/Disease Research/Clinical Labs
135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES
STONE MATTHEIS XENOPOULOS AND BREW, PC
1025 THOMAS JEFFERSON STREET, NW. #800 W, WASHINGTON, DC, 20007, US
MICHAEL N MCCARTY PATRICK BURCHETTE MICHAEL N MCCARTY PATRICK BURCHETTE